Concepedia

Publication | Open Access

Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation

DOIFull Paper Access

65

Citations

16

References

2018

Year

Marco Galluzzo, Marina Talamonti, Clara De Simone, S. D’Adamio, Gaia Moretta, Sara Tambone, Giacomo Caldarola, Maria Concetta Fargnoli, Ketty Peris, Luca Bianchi
Expert Opinion on Biological Therapy

Abstract

Secukinumab was effective in this real-life analysis, with rapid clinical improvement and long-term maintenance of results.

References

YearCitations

Page 1